Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease
Sponsor: MeiraGTx, LLC
Summary
The objective of this study is to evaluate the long-term safety of AAV-GAD delivered bilaterally to the subthalamic nuclei (STN) in participants with Parkinson's disease.
Official title: Long-term Follow-up of Glutamic Acid Decarboxylase Gene Transfer to the Subthalamic Nuclei in Participants With Parkinson's Disease
Key Details
Gender
All
Age Range
25 Years - 86 Years
Study Type
INTERVENTIONAL
Enrollment
13
Start Date
2023-05-19
Completion Date
2029-10
Last Updated
2025-08-17
Healthy Volunteers
No
Conditions
Interventions
AAV-GAD
Bilateral infusion of AAV-GAD
Locations (6)
Yale University
New Haven, Connecticut, United States
Henry Ford West Bloomfield Hospital
West Bloomfield, Michigan, United States
Weill Cornell Medicine
New York, New York, United States
Columbia University Irving Medical Center
New York, New York, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
West Virginia University
Morgantown, West Virginia, United States